Aim for the recommended daily intake (around 25-30 grams) to combat GLP-1 induced slow digestion
Clinically proven for cardiovascular, cognitive, and metabolic health benefits
For most patients, these effects diminish as the body adjusts
In previous cardiovascular outcome trials of liraglutide (LEADER) and semaglutide (SUSTAIN-6) in patients with diabetes who were at high risk for cardiovascular diseases, the risk of MACE was significantly reduced by 13% and 26%, respectively, when compared with placebo [21]
A recent study has shown that users stopping GLP-1 agonists regained weight.In a randomised controlled trial of almost 2000 subjects, obese participants treated with semaglutide plus lifestyle intervention had most of the weight loss being regained within 1 year, and a similar change in some cardiometabolic variables back to baseline after cessation of semaglutide 2
The cost of wasted semaglutide is always less than the cost of injecting a compromised compound